［1］ SUNG H,FERLAYJ,SIEGEL RL,et al.Global cancer statistics 2020:globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］.CA:A Cancer Journal for Clinicians,2021,71(3):209-249.
［2］ HANAHAN D,WEINBERG RA.Hallmarks of cancer:The next generation ［J］.Cell,2011(5):144.
［3］ KRISHNAN N,DICKMAN MB,BECKER DF.Proline modulates the intracellular redox environment and protects mammalian cells against oxidative stress ［J］.Free Radic Biol Med,2008,44(4):671-681.
［4］PANDHARE J,DONALD SP,COOPER SK,et al.Regulation and function of proline oxidase under nutrient stress ［J］.J Cell Biochem,2009,107(4):759-768.
［5］BOGNER AN,STIERS KM,TANNER JJ.Structure,biochemistry,and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase(PYCR),an emerging cancer therapy target ［J］.Amino Acids,2021,53(12):1817-1834.
［6］HU CA,BART WD,ZHAORIGET US,et al.Functional genomics and SNP analysis of human genes encoding proline metabolic enzymes［J］.Amino Acids,2008,35(4):655-664.
［7］PHANG JM,LIU W,ZABIRNYK O.Proline metabolism and microenvironmental stress ［J］.Annu Rev Nutr,2010,30:441-463.
［8］MENG Z,LOU Z,LIU Z,et al.Crystal structure of human pyrroline-5-carboxylate reductase ［J］.Journal of Molecular Biology,2006,359(5):1364-1377.
［9］CHRISTENSEN EM,PATEL SM,KORASICK DA,et al.Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1［J］.J Biol Chem,2017,292(17):7233-7243.
［10］DIMOPOULOU A,FISCHER B,GARDEITCHIK T,et al.Genotype-phenotype spectrum of PYCR1-related autosomal recessive cutis laxa［J］.Mol Genet Metab,2013,110(3):352-361.
［11］SCHERRER DZ,BAPTISTA MB,MATOS AH,et al.Mutations in PYCR1 gene in three families with autosomal recessive cutis laxa,type 2［J］.Eur J Med Genet,2013,56(6):336-339.
［12］YASUDA T,KAJI Y,AGATSUMA T,et al.DJ-1 cooperates with PYCR1 in cell protection against oxidative stress ［J］.Biochem Biophys Res Commun,2013,436(2):289-294.
［13］PHANG JM,LIU W,HANCOCK C,et al.The proline regulatory axis and cancer［J］.Front Oncol,2012,2:60.
［14］SAHU N,DELA CD,GAO M,et al.Proline starvation induces unresolved ER stress and hinders mTORC1-dependent tumorigenesis［J］.Cell Metab,2016,24(5):753-761.
［15］WESTBROOK RL,BRIDGES E,ROBERTS J,et al.Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions［J］.Cell Rep,2022,38(5):110320.
［16］ NILSSON R,JAIN M,MADHUSUDHAN N,et al.Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer［J］.Nat Commun,2014,5(1):3128.
［17］ZHUANG J,SONG Y,YE Y,et al.PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1(JNK/IRS1) pathway in hepatocellular cancer［J］.J Transl Med,2019,17(1):343.
［18］CHENG C,SONG D,WU Y,et al.RAC3 promotes proliferation,migration and invasion via PYCR1/JAK/STAT signaling in bladder cancer ［J］.Front Mol Biosci,2020,7:218.
［19］YAN K,XU X,WU T,et al.Knockdown of PYCR1 inhibits proliferation,drug resistance and EMT in colorectal cancer cells by regulating STAT3-mediated p38 MAPK and NF-kappaB signalling pathway［J］.Biochem Biophys Res Commun,2019,520(2):486-491.
［20］ ALAQBI SS,BURKE L,GUTERMAN I,et al.Increased mitochondrial proline metabolism sustains proliferation and survival of colorectal cancer cells ［J］.PLoS One,2022,17(2):e262364.
［21］ OUDAERT I,SATILMIS H,VLUMMENS P,et al.Pyrroline-5-Carboxylate Reductase 1:a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis ［J］.J Exp Clin Cancer Res,2022,41(1):45.
［22］ CAI F,MIAO Y,LIU C,et al.Pyrroline-5-carboxylate reductase 1 promotes proliferation and inhibits apoptosis in non-small cell lung cancer ［J］.Oncol Lett,2018,15(1):731-740.
［23］ GUO J,CHENG X,TIAN Y,et al.Knockdown of PYCR1 suppressed the malignant phenotype of human hepatocellular carcinoma cells via inhibiting the AKT pathway activation［J］.Reprod Biol,2021,21(3):100534.
［24］ ZENG T,ZHU L,LIAO M,et al.Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer ［J］.Medical Oncology,2017,34(2):27.
［25］ LI Z,ZHOU X,HUANG J,et al.MicroRNA hsa-miR-150-5p inhibits nasopharyngeal carcinogenesis by suppressing PYCR1(pyrroline-5-carboxylate reductase 1) ［J］.Bioengineered,2021,12(2):9766-9778.
［26］杨兴玲.PYCR1在肺癌中的表达与预后价值分析及其生物学功能研究［D］.上海:中国人民解放军海军军医大学,2021.
YANG XL.PYCR1 expression and prognostic value in lung cancer and its biological function analysis ［D］.Shanghai:Naval Medical University,2021.
［27］ZHANG J,SHANG L,JIANG W,et al.Shikonin induces apoptosis and autophagy via downregulation of pyrroline-5-carboxylate reductase1 in hepatocellular carcinoma cells ［J］.Bioengineered,2022,13(3):7904-7918.
［28］ELIA I,BROEKAERT D,CHRISTEN S,et al.Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells ［J］.Nature Communications,2017,8(1):15267.
［29］PHANG JM,LIU W,HANCOCK CN,et al.Proline metabolism and cancer:emerging links to glutamine and collagen ［J］.Curr Opin Clin Nutr Metab Care,2015,18(1):71-77.
［30］SHE Y,MAO A,LI F,et al.P5CR1 protein expression and the effect of gene-silencing on lung adenocarcinoma［J］.Peer J,2019,7(1):e6934.
［31］TAN B,YOUNG DA,LU ZH,et al.Pharmacological inhibition of nicotinamide phosphoribosyltransferase(NAMPT),an enzyme essential for NAD+ biosynthesis,in human cancer cells:metabolic basis and potential clinical implications［J］.J Biol Chem,2013,288(5):3500-3511.
［32］YAMAMOTO M,INOHARA H,NAKAGAWA T.Targeting metabolic pathways for head and neck cancers therapeutics［J］.Cancer Metastasis Rev,2017,36(3):503-514.
［33］DHUP S,DADHICH RK,PORPORATO PE,et al.Multiple biological activities of lactic acid in cancer:influences on tumor growth,angiogenesis and metastasis ［J］.Curr Pharm Des,2012,18(10):1319-1330.
［34］DU S,SUI Y,REN W,et al.PYCR1 promotes bladder cancer by affecting the Akt/Wnt/beta-catenin signaling ［J］.J Bioenerg Biomembr,2021,53(2):247-258.
［35］KAY EJ,PATERSON K,RIERA-DOMINGO C,et al.Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix ［J］.Nat Metab,2022,4(6):693-710.
［36］SANG S,ZHANG C,SHAN J.Pyrroline-5-carboxylate reductase 1 accelerates the migration and invasion of nonsmall cell lung cancer in vitro ［J］.Cancer Biother Radiopharm,2019,34(6):380-387.
［37］XU Y,ZUO W,WANG X,et al.Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma［J］.Int J Biol Sci,2021,17(9):2223-2239.
［38］FANG K,SUN M,LENG Z,et al.Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia［J］.J Exp Clin Cancer Res,2023,42(1):73-90.
［39］DING J,KUO ML,SU L,et al.Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers ［J］.Carcinogenesis,2017,38(5):519-531.
［40］ XIAO S,LI S,YUAN Z,et al.Pyrroline-5-carboxylate reductase 1(PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome ［J］.Ann Transl Med,2020,8(15):937.
［41］ DARZI M,GORGIN S,MAJIDZADEH AK,et al.Gene co-expression network analysis reveals immune cell infiltration as a favorable prognostic marker in non-uterine leiomyosarcoma［J］.Sci Rep,2021,11(1):2339.
［42］ FU WJ,XIE ZB,ZHENG SF,et al.The clinical significance of PYCR1 expression in renal cell carcinoma［J］.Medicine,2019,98(28):e16384.
［43］ WANG QL,LIU L.PYCR1 is associated with papillary renal cell carcinoma progression ［J］.Open Med(Wars),2019,14:586-592.
［44］ ZHANG LH,ZHAO XY,WANG EQ,et al.PYCR1 promotes the malignant progression of lung cancer through the JAK-STAT3 signaling pathway via PRODH-dependent glutamine synthesize［J］.Transl Oncol,2023,32(1):1-13.
［45］ FANG E,WANG X,YANG F,et al.Therapeutic targeting of MZF1-AS1/PARP1/E2F1 axis inhibits proline synthesis and neuroblastoma progression ［J］.Advanced Science,2019,6(19):1900581.
［46］ CRAZE ML,CHEUNG H,JEWA N,et al.MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer ［J］.British Journal of Cancer,2018,118(2):258-265.
［47］LIU W,LE A,HANCOCK C,et al.Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC［J］.Proc Natl Acad Sci USA,2012,109(23):8983-8988.
［48］ GAO Y,LUO L,XIE Y,et al.PYCR1 knockdown inhibits the proliferation,migration,and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma［J］.Mol Carcinog,2020,59(5):503-511.
［49］GUO L,CUI C,ZHANG K,et al.Kindlin-2 links mechano-environment to proline synthesis and tumor growth［J］.Nat Commun,2019,10(1):845.
［50］CHEN K,GUO L,WU C.How signaling pathways link extracellular mechano-environment to proline biosynthesis:A hypothesis:PINCH-1 and kindlin-2 sense mechanical signals from extracellular matrix and link them to proline biosynthesis［J］.Bioessays,2021,43(9):e2100116.
［51］ XIAO S,YAO X,YE J,et al.Epigenetic modification facilitates proline synthase PYCR1 aberrant expression in gastric cancer ［J］.Biochim Biophys Acta Gene Regul Mech,2022,1865(6):194829.
［52］ HU F,ZENG W,LIU X.A Gene signature of survival prediction for kidney renal cell carcinoma by multi-omic data analysis［J］.Int J Mol Sci,2019,20(22):5720.
［53］ SONG W,YANG K,LUO J,et al.Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression［J］.Aging(Albany NY),2021,13(3):3909-3925.
［54］ CHEN S,YANG X,YU M,et al.SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism ［J］.Neoplasia,2019,21(7):665-675.
［55］WANG Q,XIE Z,LI C,et al.CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1［J］.Journal of Molecular Histology,2022,53(4):657-667.
［56］ LU J,LIN J,ZHOU Y,et al.miR-328-3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1 ［J］.Biochem Biophys Res Commun,2021,550:99-106.
［57］ WANG D,WANG L,ZHANG Y,et al.PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488［J］.Biomed Pharmacother,2019,111:588-595.
［58］ CUI JQ,YI YT,LIN KW,et al.Circ_0000705 facilitates proline metabolism of esophageal squamous cell carcinoma cells by targeting miR-621/PYCR1 axis ［J］.Discover Oncology,2022,13(1):50.
［59］ XU H,HE Y,LIN L,et al.miR-1207-5p targets PYCR1 to inhibit the progression of prostate cancer ［J］.Biochem Biophys Res Commun,2021,575:56-64.
［60］ MILNE K,SUN J,ZAAL EA,et al.A fragment-like approach to PYCR1 inhibition［J］.Bioorg Med Chem Lett,2019,29(18):2626-2631.
［61］ CHRISTENSEN EM,BOGNER AN,VANDEKEERE A,et al.In crystallo screening for proline analog inhibitors of the proline cycle enzyme PYCR1［J］.J Biol Chem,2020,295(52):18316-18327.
［62］ FORLANI G,SABBIONI G,RAGNO D,et al.Phenyl-substituted aminomethylene-bisphosphonates inhibit human P5C reductase and show antiproliferative activity against proline-hyperproducingtumour cells［J］.J Enzyme Inhib Med Chem,2021,36(1):1248-1257.